Clinical Outcomes And Predictors Of Mortality In COVID-19 Patients Admitted To A High Dependency Unit In Pakistan-A

Samar Fatima1, Sara Shamim1, Taymmia Ejaz1

  • 1Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan.

Insights

In-hospital mortality for coronavirus disease 2019 (COVID-19) patients in high dependency units was 11%. Older age and multimorbidity were key predictors of mortality in these critically ill COVID-19 patients.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Coronavirus disease 2019 (COVID-19) poses a significant global health threat, necessitating research into patient outcomes in critical care settings.
  • High dependency units (HDUs) manage patients with severe COVID-19 requiring close monitoring and intervention.

Purpose of the Study:

  • To investigate the outcomes of patients admitted to the high dependency unit with COVID-19.
  • To identify predictors of in-hospital mortality among these patients.

Main Methods:

  • A retrospective study was conducted at a tertiary care hospital in Karachi, Pakistan.
  • Data from adult COVID-19 patients admitted to the HDU between March 1 and June 30, 2020, were analyzed.
  • Outcomes were categorized as recovered, deteriorated but survived, or expired. Statistical analysis was performed using SPSS 22.

Main Results:

  • Out of 245 admitted patients, 207 formed the study sample after excluding those with missing data.
  • The overall in-hospital mortality rate was 11% (23 out of 207 patients).
  • Significant predictors of disease progression and mortality included older age, multimorbidity, and elevated D-Dimer levels (p<0.05).

Conclusions:

  • Mortality in the HDU setting for COVID-19 patients was substantial.
  • Older patients and those with multiple comorbidities faced a higher risk of mortality.
  • Early identification of these risk factors is crucial for improving patient management and outcomes in severe COVID-19 cases.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
258
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
269
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
237
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
159
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
213
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
357